Clinical Trials Sponsored by Mundipharma Oy

Total 394 results

Hutchison Medipharma Limited

Completed

A Food Effect Phase I Study of the Sulfatinib in Healthy Subjects (HMPL-012)

Healthy

China
Hutchison Medipharma Limited

Completed

A Phase I Study of Epitinib(HMPL-813) in Patients With Advanced Solid Tumors

Solid Tumor

China
Hutchison Medipharma Limited

Completed

Food Effect Study of Single Dose of Fruquintinib (HMPL-013) in Healthy Subjects

Food Effect of Fruquintinib in Health Subjects

China
Hutchison Medipharma Limited

Completed

A Phase Ib/2 Clinical Study of Fruquintinib Combined With Paclitaxel in the Treatment of Advanced Gastric Cancer

Gastric Cancer

China
Hutchison Medipharma Limited

Unknown

A Study of HMPL-453 in Patients With Advanced Solid Malignancies

Solid Tumor, Adult

China
Hutchison Medipharma Limited

Completed

A Mass Balance Study to Investigate the Absorption, Metabolism, and Excretion Of [14C] Fruquintinib

Healthy

China
Hutchison Medipharma Limited

Completed

Study of Sulfatinib in Treating Advanced Medullary Thyroid Carcinoma and Iodine-refractory Differentiated Thyroid Carcinoma

Thyroid Carcinoma

China
Hutchison Medipharma Limited

Completed

Phase II Study of HMPL-004 in Subjects With Crohn's Disease

Crohn's Disease
Hutchison Medipharma Limited

Completed

A Phase III Clinical Trial of Fruquintinib in Patients With Advanced Non-small Cell Lung Cancer (FALUCA)

NSCLC

China
Hutchison Medipharma Limited

Terminated

A Dose Escalation Study to Assess the Safety and Tolerability of HMPL-453 in Patients With Advanced Solid Malignancies

Solid Tumor

Australia
Hutchison Medipharma Limited

Completed

Phase Ib/II Study of Sulfatinib in Treating Advanced Neuroendocrine Tumors

Neuroendocrine Tumors

China
Turku University Hospital
European Commission; Ocuspecto Oy

Unknown

Assessing Neurovisual Function in Patients With Cognitive Impairment

Glaucoma | Healthy | Mild Cognitive Impairment | Glaucoma and Mild Cognitive Impairment

Finland
Chalmers University of Technology
Oy Foodfiles Ltd

Completed

Postprandial Differences After Herring and Beef

Cardiovascular Disease
Kanta-Häme Central Hospital
Linnan Klinikka Oy

Completed

Hämeenlinna Metabolic Syndrome Research Program: Oxidized LDL and Arterial Elasticity in Metabolic Syndrome and Controls (HMS-01) (HMS-01)

Metabolic Syndrome

Finland
Koite Health Oy
Karolinska Institutet; University of Helsinki

Withdrawn

Regular Antibacterial Photodynamic Therapy on Oral Hygiene in the Elderly 24-hour Care

Plaque | Inflamed Gums | Dryness Oral

Sweden
Taichung Veterans General Hospital
Taiwan Mundipharma Pharmaceuticals Ltd.

Unknown

Human Physiology and Self-Reported Pain Score

Cancer Pain

Taiwan
Mundipharma Manufacturing Pte Ltd.
Genome Institute of Singapore

Completed

The Effect of Skin Cleansers on the Skin Surface Microbiome

Skin Health

Singapore
Nilminie Rathnayake
University of Helsinki

Not yet recruiting

Antibacterial Photodynamic Therapy in the Management of Peri-implantitis

Peri-Implantitis | Plaque, Dental

Sweden
The University of Hong Kong
Icare Finland Oy

Not yet recruiting

Impact of Home Intraocular Pressure Telemonitoring on Intraocular Pressure Control and Glaucoma Progression

Primary Open Angle Glaucoma | Glaucoma | Intraocular Pressure
Mun Wai Lee
Santen Oy

Recruiting

Dry Eye Management With 3% Diquafosol Before and After Cataract Surgery

Dry Eye

Malaysia
University of Oulu
Oulu University Hospital; Cerenion Oy

Completed

EEG Slow Wave Activity in Hypoxic Brain Injury (BrainICU)

Cardiac Arrest | Hypoxic-Ischemic Encephalopathy

Finland
Turku University Hospital
Tampere University Hospital; Sooma Oy

Unknown

Transcranial Direct Current Stimulation (tDCS) as an add-on Therapy for Treatment of Major Depressive Disorder. (DEPTDCS2014)

Depression

Finland, Sweden
Nordic Lymphoma Group
Mundipharma Pte Ltd.; Amgen

Completed

CHemoImmunotherapy With Early Central Nervous System (CNS) Prophylaxis (CHIC)

Primary Disease

Denmark, Finland, Norway, Sweden
National University Hospital, Singapore
Mundipharma Pte Ltd.

Unknown

The Efficacy and Safety of 3% Povidone-Iodine in Acne Therapy

Acne

Singapore
Mundipharma Pharmaceuticals S.L.
Alpha Bioresearch S.L.; Dynamic Solutions

Withdrawn

Efficiency Control of Fluticasone/Formoterol K-haler (Medium Strength) vs ICS/LABA (High Strength) in Asthma Patients

Persistent Asthma
PETHEMA Foundation
Janssen-Cilag Ltd.; Mundipharma Pharmaceuticals B.V.

Completed

Bendamustine, Bortezomib (Velcade ®) and Prednisone (BVP) in Patients Newly Diagnosed Multiple Myeloma

Multiple Myeloma

Spain
Research in Real-Life Ltd
Mundipharma Research Limited

Completed

Real-world Effectiveness of Combination Therapy in Asthma

Asthma

United Kingdom
Hutchison Medipharma Limited
AstraZeneca

Completed

A Study of Safety and Pharmacokinetics of Volitinib With Docetaxel in Patients With Advanced Gastric Cancer

Gastric Cancer

China
Hutchison Medipharma Limited

Recruiting

Efficacy and Safety of Fruquintinib in Combination With Sintilimab in Advanced Renal Cell Carcinoma (FRUSICA-2)

Advanced Renal Cell Carcinoma

China
Hutchison Medipharma Limited

Recruiting

Surufatinib Plus Anti-PD-1/L1 as Maintenance Therapy in Extensive-Stage Small Cell Lung Cancer

Extensive-Stage Small Cell Lung Cancer

China
Hutchison Medipharma Limited

Recruiting

Clinical Study of HMPL-653 in Treatment of Advanced Malignant Solid Tumors and TGCT

Advanced Malignant Solid Tumors | TGCT

China
Hutchison Medipharma Limited

Recruiting

HMPL-453 (FGFR Inhibitor) in Combination With Chemotherapy or Anti-PD-1 Antibody in Advanced Solid Tumors

Solid Tumor

China
Hutchison Medipharma Limited

Recruiting

Study on Savolitinib Combined With Osimertinib in Treatment of Advanced NSCLC With MET Amplification (SACHI)

Non-small Cell Lung Cancer

China
Hutchison Medipharma Limited

Completed

A Multi-Center, Open-Label Study of Surufatinib (HMPL-012) in Patients With Advanced Solid Tumors

Tumors

United States, Italy
Hutchison Medipharma Limited

Active, not recruiting

HMPL-523 (Sovleplenib) in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia (wAIHA)

Warm Antibody Autoimmune Hemolytic Anemia

China
Hutchison Medipharma Limited

Completed

Surufatinib Hepatic Impairment Study

Hepatic Impairment

United States
Hutchison Medipharma Limited

Active, not recruiting

A Phase II Study of HMPL-504 in Lung Sarcomatoid Carcinoma and Other Non-small Cell Lung Cancer

Lung Sarcomatoid Carcinoma

China
Hutchison Medipharma Limited

Completed

A Study to Assess the Effect of a Strong CYP3A Inhibitor, on Surufatinib in Healthy Subjects

Healthy

United States
Hutchison Medipharma Limited

Unknown

A Trial Evaluating Surufatinib Efficacy and Safety in Biliary Tract Carcinoma Patients

Biliary Tract Cancer

China
Hutchison Medipharma Limited

Terminated

Phase I Study of HMPL-523+Azacitidine in Elderly Patients With Acute Myeloid Leukemia

Acute Myeloid Leukemia

China
Hutchison Medipharma Limited

Completed

A Phase II Study of Fruquintinib in Combination With Gefitinib in Patients With Advanced Non-small Cell Lung Cancer

NSCLC

China
Hutchison Medipharma Limited

Completed

Phase I Study of the Volitinib (HMPL-504) in Patients With Advanced Solid Tumors (HMPL-504)

Tumors

China
Hutchison Medipharma Limited

Completed

A Food Effect Phase I Study of the Volitinib in Healthy Subjects (HMPL-504)

Food Effect | Health Subjects

China
Hutchison Medipharma Limited

Completed

Phase I Clinical Trial in Healthy Male Volunteers

Inflammatory Bowel Diseases
Hutchison Medipharma Limited

Terminated

Study of Theliatinib (HMPL-309) in Patients With Advanced Solid Tumor (HMPL-309)

Cancer

China
Hutchison Medipharma Limited

Completed

To Explore the Pharmacokinetics and Relative Bioavailability of Sulfatinib Capsules in Two Different Manufacturers (CRC-C1721)

Relative Bioavailability

China
Hutchison Medipharma Limited

Completed

A Study of HMPL-689 in Healthy Volunteers

Healthy Volunteers

Australia
University of Oulu
South Carelia Central Hospital; Cerenion Oy

Recruiting

EEG Changes During Induction of Propofol Anesthesia (PropoStatus)

Anesthesia, General | Healthy Subjects

Finland
Herantis Pharma Plc.
Clinical Research Services Turku - CRST Oy

Completed

Single Ascending Doses of HER-096 in Healthy Subjects

Parkinson Disease

Finland
Turku University Hospital
University of Turku; WellO2 Oy

Recruiting

Muscle Strength Exercise and Sleep Apnea

Sleep Apnea

Finland

Clinical Trials Sponsored by Mundipharma Oy

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ireland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations